Business Description
Precigen Inc
NAICS : 541714
SIC : 8731
ISIN : US74017N1054
Share Class Description:
PGEN: Ordinary SharesTotal Employee Number:
47Description
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.57 | |||||
Equity-to-Asset | 0.15 | |||||
Debt-to-Equity | 4.86 | |||||
Debt-to-EBITDA | -0.51 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -17.88 | |||||
Beneish M-Score | 4.75 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -38.6 | |||||
3-Year EBITDA Growth Rate | -35.6 | |||||
3-Year EPS without NRI Growth Rate | -32.3 | |||||
3-Year FCF Growth Rate | 6.3 | |||||
3-Year Book Growth Rate | -54 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 233.41 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 38.27 | |||||
9-Day RSI | 50.9 | |||||
14-Day RSI | 55.56 | |||||
3-1 Month Momentum % | -6.49 | |||||
6-1 Month Momentum % | -15.25 | |||||
12-1 Month Momentum % | 103.66 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.82 | |||||
Quick Ratio | 4.12 | |||||
Cash Ratio | 2.67 | |||||
Days Inventory | 529.99 | |||||
Days Sales Outstanding | 73.88 | |||||
Days Payable | 323.81 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -19.4 | |||||
Shareholder Yield % | -3.58 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 80.12 | |||||
Operating Margin % | -284.85 | |||||
Net Margin % | -647 | |||||
EBITDA Margin % | -613.93 | |||||
FCF Margin % | -370.2 | |||||
OCF Margin % | -365.04 | |||||
ROE % | -3176.66 | |||||
ROA % | -146.84 | |||||
ROIC % | -164.33 | |||||
3-Year ROIIC % | 33.33 | |||||
ROC (Joel Greenblatt) % | -826 | |||||
ROCE % | -176.96 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 57.88 | |||||
PB Ratio | 93.42 | |||||
Price-to-Tangible-Book | 532.5 | |||||
EV-to-EBIT | -9.82 | |||||
EV-to-EBITDA | -10 | |||||
EV-to-Revenue | 61.42 | |||||
EV-to-Forward-Revenue | 14.72 | |||||
EV-to-FCF | -16.59 | |||||
Price-to-GF-Value | 0.87 | |||||
Price-to-Median-PS-Value | 4.26 | |||||
Earnings Yield (Greenblatt) % | -10.18 | |||||
FCF Yield % | -6.16 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:PGEN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Precigen Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 31.595 | ||
| EPS (TTM) ($) | -1.18 | ||
| Beta | 0.7406 | ||
| 3-Year Sharpe Ratio | 0.8 | ||
| 3-Year Sortino Ratio | 2.47 | ||
| Volatility % | 168.52 | ||
| 14-Day RSI | 55.56 | ||
| 14-Day ATR ($) | 0.333392 | ||
| 20-Day SMA ($) | 5.28175 | ||
| 12-1 Month Momentum % | 103.66 | ||
| 52-Week Range ($) | 1.47 - 6.04 | ||
| Shares Outstanding (Mil) | 356.51 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Precigen Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Precigen Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-13 16:30 | In 125 days | ||
| Third quarter earnings results for 2026 | 2026-11-13 | In 124 days | ||
| Second quarter earnings results for 2026 | 2026-08-12 | In 31 days | ||
| General meeting for 2026 | 2026-06-18 09:00 | 4.73 (-0.63%) | ||
| Goldman Sachs 47th Annual Global Healthcare Conference | 2026-06-08 09:20 | 3.58 (-6.77%) | ||
| J.P. Morgan fireside chat | 2026-06-01 10:00 | 4.34 (-3.34%) | ||
| First quarter earnings conference call for 2026 | 2026-05-13 16:30 | 4.08 (-1.92%) | ||
| First quarter earnings results for 2026 | 2026-05-13 | 4.08 (-1.92%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-25 16:30 | 3.13 (-2.19%) | ||
| Annual report for 2025 | 2026-03-25 | 3.13 (-2.19%) |
Show
Entries
Precigen Inc Frequently Asked Questions
What is Precigen Inc(PGEN)'s stock price today?
The current price of PGEN is $5.33. The 52 week high of PGEN is $6.04 and 52 week low is $1.47.
When is next earnings date of Precigen Inc(PGEN)?
The next earnings date of Precigen Inc(PGEN) is 2026-08-12 Est..
Does Precigen Inc(PGEN) pay dividends? If so, how much?
Precigen Inc(PGEN) does not pay dividend.
Guru Commentaries on NAS:PGEN
No articles.
Press Release
Articles on Precigen Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers